Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing
暂无分享,去创建一个
Charles J. Vaske | Nader Pourmand | Charles Joseph Vaske | Beverly M. Emerson | Fernando J. Lopez-Diaz | H. Kim | N. Pourmand | Amie Radenbaugh | B. Emerson | M. W. Lee | F. Lopez-Diaz | S. Y. Khan | M. Tariq | Yelena Dayn | Hyunsung John Kim | Mei-Chong Wendy Lee | Shahid Yar Khan | Muhammad Akram Tariq | Yelena Dayn | Amie J. Radenbaugh
[1] H. Ueda,et al. Erratum to: Quartz-Seq: a highly reproducible and sensitive single-cell RNA sequencing method, reveals non-genetic gene-expression heterogeneity , 2017, Genome Biology.
[2] A. Saliba,et al. Single-cell RNA-seq: advances and future challenges , 2014, Nucleic acids research.
[3] Jian Lu,et al. Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals , 2014, Proceedings of the National Academy of Sciences.
[4] N. Xu,et al. CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl‐2/Bax family proteins during treatment with microtubule interfering agents , 2014, Cell biology international.
[5] B. Williams,et al. From single-cell to cell-pool transcriptomes: Stochasticity in gene expression and RNA splicing , 2014, Genome research.
[6] Joshua M. Stuart,et al. RADIA: RNA and DNA Integrated Analysis for Somatic Mutation Detection , 2014, PloS one.
[7] C. Ponting,et al. Sequencing depth and coverage: key considerations in genomic analyses , 2014, Nature Reviews Genetics.
[8] Steven R. Head,et al. Technical Variations in Low-Input RNA-seq Methodologies , 2014, Scientific Reports.
[9] Gioele La Manno,et al. Quantitative single-cell RNA-seq with unique molecular identifiers , 2013, Nature Methods.
[10] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[11] N. Neff,et al. Quantitative assessment of single-cell RNA-sequencing methods , 2013, Nature Methods.
[12] Alan Jones,et al. To whom correspondence should be addressed , 2014 .
[13] M. Wicha,et al. Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells , 2013, PloS one.
[14] F. Gage,et al. RNA-sequencing from single nuclei , 2013, Proceedings of the National Academy of Sciences.
[15] Laura M. Heiser,et al. Modeling precision treatment of breast cancer , 2013, Genome Biology.
[16] Ruiqiang Li,et al. Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells , 2013, Nature Structural &Molecular Biology.
[17] T. Masuda,et al. BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells , 2013, Experimental dermatology.
[18] D. Yardley,et al. Drug Resistance and the Role of Combination Chemotherapy in Improving Patient Outcomes , 2013, International journal of breast cancer.
[19] P. Gascard,et al. Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response. , 2013, Molecular cell.
[20] Rona S. Gertner,et al. Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells , 2013, Nature.
[21] Rahul Kumar,et al. CancerDR: Cancer Drug Resistance Database , 2013, Scientific Reports.
[22] Jin Billy Li,et al. Edinburgh Research Explorer Identifying Rna Editing Sites Using Rna Sequencing Data Alone , 2022 .
[23] Kornelia Polyak,et al. Cellular heterogeneity and molecular evolution in cancer. , 2013, Annual review of pathology.
[24] Kendra N. Pesko,et al. Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification , 2012, Nucleic acids research.
[25] P. Mariani,et al. Assessment of MDA efficiency for genotyping using cloned embryo biopsies. , 2013, Genomics.
[26] Jiang Li,et al. The effect of strand bias in Illumina short-read sequencing data , 2012, BMC Genomics.
[27] M. Ronaghi,et al. mRNA-Seq of Single Prostate Cancer Circulating Tumor Cells Reveals Recapitulation of Gene Expression and Pathways Found in Prostate Cancer , 2012, PloS one.
[28] A. Wilm,et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets , 2012, Nucleic acids research.
[29] C. Swanton. Intratumor heterogeneity: evolution through space and time. , 2012, Cancer research.
[30] T. Hashimshony,et al. CEL-Seq: single-cell RNA-Seq by multiplexed linear amplification. , 2012, Cell reports.
[31] Jacek Majewski,et al. RNA editing of protein sequences: a rare event in human transcriptomes. , 2012, RNA.
[32] B. Williams,et al. RNA editing in the human ENCODE RNA-seq data , 2012, Genome research.
[33] Wei Li,et al. RSeQC: quality control of RNA-seq experiments , 2012, Bioinform..
[34] H. Swerdlow,et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers , 2012, BMC Genomics.
[35] Richard S. Sandstrom,et al. BEDOPS: high-performance genomic feature operations , 2012, Bioinform..
[36] R. Minchin,et al. Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives , 2012, EMBO molecular medicine.
[37] R. Sandberg,et al. Full-Length mRNA-Seq from single cell levels of RNA and individual circulating tumor cells , 2012, Nature Biotechnology.
[38] Thomas Lengauer,et al. Managing drug resistance in cancer: lessons from HIV therapy , 2012, Nature Reviews Cancer.
[39] Matthew A. Hibbs,et al. Canonical A-to-I and C-to-U RNA Editing Is Enriched at 3′UTRs and microRNA Target Sites in Multiple Mouse Tissues , 2012, PloS one.
[40] William A. Walters,et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.
[41] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[42] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[43] Huanming Yang,et al. Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor , 2012, Cell.
[44] Wenwei Zhang,et al. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome , 2012, Nature Biotechnology.
[45] Mark A van de Wiel,et al. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain , 2012, The Journal of pathology.
[46] Ken Chen,et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data , 2012, Bioinform..
[47] Kazuhiro Morishita,et al. The Increased Expression of Integrin α6 (ITGA6) Enhances Drug Resistance in EVI1high Leukemia , 2012, PloS one.
[48] T. Crook,et al. Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells , 2012, Cell Death and Disease.
[49] J. Z. Sanborn. Tumor versus Matched-Normal Sequencing Analysis and Data Integration , 2012 .
[50] Jae-Hyung Lee,et al. Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. , 2012, Genome research.
[51] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[52] M. Ruíz-Borrego,et al. Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction , 2012, Breast Cancer Research and Treatment.
[53] C. Baines,et al. The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death , 2011, Cell cycle.
[54] Pradeep S Rajendran,et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.
[55] R. Bast,et al. Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. , 2011, Cancer research.
[56] Nader Pourmand,et al. Whole-transcriptome RNAseq analysis from minute amount of total RNA , 2011, Nucleic acids research.
[57] S. Linnarsson,et al. Characterization of the single-cell transcriptional landscape by highly multiplex RNA-seq. , 2011, Genome research.
[58] G. Heusch,et al. Nuclear-encoded mitochondrial proteins and their role in cardioprotection. , 2011, Biochimica et biophysica acta.
[59] Xiaolong Yang,et al. Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. , 2011, Cancer research.
[60] T. Merriam,et al. Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia. , 2011, Biochemical and biophysical research communications.
[61] Elaine R. Mardis,et al. A decade’s perspective on DNA sequencing technology , 2011, Nature.
[62] A. Pobbati,et al. Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin* , 2011, The Journal of Biological Chemistry.
[63] F. Kronenberg,et al. Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. , 2010, American journal of human genetics.
[64] Jonathan W. Pillow,et al. POSTER PRESENTATION Open Access , 2013 .
[65] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[66] B. Ward,et al. Transplex? Whole Transcriptome Amplification of RNA from Low Cell-Number Samples. , 2010 .
[67] Yu Shyr,et al. RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells , 2010, Breast Cancer Research.
[68] K. Nishikura. Functions and regulation of RNA editing by ADAR deaminases. , 2010, Annual review of biochemistry.
[69] Wei Xiong,et al. MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression* , 2010, The Journal of Biological Chemistry.
[70] Ben S. Wittner,et al. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.
[71] Catalin C. Barbacioru,et al. RNA-Seq analysis to capture the transcriptome landscape of a single cell , 2010, Nature Protocols.
[72] L. Tsai,et al. Hook3 Interacts with PCM1 to Regulate Pericentriolar Material Assembly and the Timing of Neurogenesis , 2010, Neuron.
[73] S. Brunak,et al. Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis , 2010, Science Signaling.
[74] Ashraful Hoque,et al. Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies , 2010, Human mutation.
[75] Xuegong Zhang,et al. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data , 2010, Bioinform..
[76] Yuan Tian,et al. Quantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with paclitaxel resistance , 2009, Proteomics. Clinical applications.
[77] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[78] Lior Pachter,et al. Sequence Analysis , 2020, Definitions.
[79] Huilin Zhou,et al. hNOA1 Interacts with Complex I and DAP3 and Regulates Mitochondrial Respiration and Apoptosis* , 2009, Journal of Biological Chemistry.
[80] N. Samadi,et al. Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis , 2009, Oncogene.
[81] N. Tanaka,et al. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. , 2009, International journal of oncology.
[82] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[83] G. Hortobagyi,et al. Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells , 2009, Breast Cancer Research.
[84] A. Letai,et al. Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737. , 2008, Cancer research.
[85] G. Glatting,et al. Activation of intrinsic apoptotic pathway by Re-188 irradiation and paclitaxel in coronary artery smooth muscle cells. , 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[86] S. Elledge,et al. A quantitative atlas of mitotic phosphorylation , 2008, Proceedings of the National Academy of Sciences.
[87] S. Carr,et al. A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology , 2008, Cell.
[88] B. Williams,et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.
[89] Sherif Abou Elela,et al. Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes , 2008, Molecular Cancer Therapeutics.
[90] Barbara McGrogan,et al. Taxanes, microtubules and chemoresistant breast cancer. , 2008, Biochimica et biophysica acta.
[91] Sébastien Lê,et al. FactoMineR: An R Package for Multivariate Analysis , 2008 .
[92] Nanlan Xu,et al. Whole genome amplification using single‐primer PCR , 2008, Biotechnology journal.
[93] Seema Sehrawat,et al. Role of Epac1, an exchange factor for Rap GTPase, in endothelial microtubule dynamics and barrier function , 2007, Molecular biology of the cell.
[94] Shawn Levy,et al. Complementary RNA amplification methods enhance microarray identification of transcripts expressed in the C. elegans nervous system , 2008, BMC Genomics.
[95] Pierre Baldi,et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny , 2006, Nucleic Acids Res..
[96] Marty C. Brandon,et al. Mitochondrial mutations in cancer , 2006, Oncogene.
[97] Sambasiva P Rao,et al. Accurate and precise transcriptional profiles from 50 pg of total RNA or 100 flow-sorted primary lymphocytes. , 2006, Genomics.
[98] E. Thompson,et al. Evi1 is a survival factor which conveys resistance to both TGFβ- and taxol-mediated cell death via PI3K/AKT , 2006, Oncogene.
[99] Hidetoshi Shimodaira,et al. Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..
[100] Xiaoqi Liu,et al. A mammalian NudC-like protein essential for dynein stability and cell viability. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[101] Huai-gu Zhou,et al. [Study on application of the whole genome amplification in LCN]. , 2006, Fa yi xue za zhi.
[102] Anne Kopf-Sill,et al. Novel isothermal, linear nucleic acid amplification systems for highly multiplexed applications. , 2005, Clinical chemistry.
[103] M. Magiera,et al. Exchange protein directly activated by cAMP (EPAC) interacts with the light chain (LC) 2 of MAP1A. , 2004, The Biochemical journal.
[104] Xiaoju Wang,et al. Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer , 2004, Cancer Research.
[105] Ming-Tsan Lin,et al. Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-κB-dependent XIAP Up-Regulation* , 2004, Journal of Biological Chemistry.
[106] Zhuchu Chen,et al. [Expression and structure of BNIP3L in lung cancer]. , 2004, Ai zheng = Aizheng = Chinese journal of cancer.
[107] Terrence S. Furey,et al. The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..
[108] M. Campbell,et al. PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.
[109] M. Raffeld,et al. The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation. , 2003, Blood.
[110] Xiaoqi Liu,et al. A role for Plk1 phosphorylation of NudC in cytokinesis. , 2003, Developmental cell.
[111] S. Dimauro,et al. Mitochondrial respiratory-chain diseases. , 2003, The New England journal of medicine.
[112] F. J. Livesey. Strategies for microarray analysis of limiting amounts of RNA. , 2003, Briefings in functional genomics & proteomics.
[113] A. Merdes,et al. Assembly of centrosomal proteins and microtubule organization depends on PCM-1 , 2002, The Journal of cell biology.
[114] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[115] W. J. Kent,et al. BLAT--the BLAST-like alignment tool. , 2002, Genome research.
[116] M. Gottesman. Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.
[117] M. Mann,et al. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[118] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[119] 田上 真次. A novel protein,RTN-xS,interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity , 2001 .
[120] M. Takeda,et al. A novel protein, RTN-xS, interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity , 2000, Oncogene.
[121] T. Lüscher,et al. Connective Tissue Growth Factor Induces Apoptosis in Human Breast Cancer Cell Line MCF-7* , 1999, The Journal of Biological Chemistry.
[122] M. Tattersall,et al. Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[123] K. Sirotkin,et al. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. , 1999, Genome research.
[124] J. Ingle,et al. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[125] T. Fujiwara,et al. Isolation, mapping, and functional analysis of a novel human cDNA (BNIP3L) encoding a protein homologous to human NIP3 , 1998, Genes, chromosomes & cancer.
[126] B. Brinkley,et al. Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. , 1998, Cell motility and the cytoskeleton.
[127] Stuart Tugendreich,et al. CDC27Hs colocalizes with CDC16Hs to the centrosome and mitotic spindle and is essential for the metaphase to anaphase transition , 1995, Cell.
[128] B. Pedrotti,et al. Purified native microtubule associated protein MAP1A: kinetics of microtubule assembly and MAP1A/tubulin stoichiometry. , 1994, Biochemistry.
[129] J. W. Wilson,et al. Taxol: a history of pharmaceutical development and current pharmaceutical concerns. , 1993, Journal of the National Cancer Institute. Monographs.
[130] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[131] K. Mullis,et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.
[132] 城所 良明,et al. The Salk Institute for Biological Studies(話題) , 1975 .